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CORRECTION
Correction: Amniotic ectoderm expansion in mouse occurs via
distinct modes and requires SMAD5-mediated signalling
(doi: 10.1242/dev.157222)
Mariya P. Dobreva, Vanesa Abon Escalona, Kirstie A. Lawson, Marina N. Sanchez, Ljuba C. Ponomarev,
Paulo N. G. Pereira, Agata Stryjewska, Nathan Criem, Danny Huylebroeck, Susana M. Chuva de Sousa Lopes,
Stein Aerts and An Zwijsen
There were errors in Development (2018) 145, dev157222 (doi: 10.1242/dev.157222).
On p.1, the sentence should read ‘This causes amnion-chorion separation and results in three cavities at E7.5: the amniotic and ectoplacental
cavities, and the de novo-derived exocoelomic (visceral yolk sac) cavity.’
Fig. 1 and its legend contained an error. The correct figure and legend are provided below.
The authors also received funds from the Onderzoeksraad KU Leuven (GOA/11/012).
We and the authors apologise to readers for these mistakes.
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Fig. 1. Amnion fate map. Fate maps of amniotic ectoderm and amniotic mesoderm. Top left: cartoon of a midsagittal section of an E6.2, prestreak stage
(PS) embryo. The proximal half of the epiblast cup (blue pattern) is expanded in the right panels and projected on the sagittal midline of PS and early-streak
(ES) stages. Left and right halves of the epiblast are superimposed. Half the circumference of the normalized epiblast is flattened and fitted to its diameter (D),
i.e. πD/2 is reduced to D. The primitive streak is represented by a grey stripe. The composition (to the nearest 10%) of clones contributing to amnion is shown
as pie charts at the positions of clone initiation in the two upper panels. Clones not contributing to the amnion are represented by empty circles. Lower panel:
composition of the clones not contributing to amniotic ectoderm in the same region as in the upper panel. Clones contributing to amniotic ectoderm are not
represented for clarity. Scale bar: 50 μm. A, anterior; AVE, anterior visceral endoderm; Epi, epiblast; EPC, ectoplacental cone; EVE, embryonic visceral
endoderm; ExEc, extraembryonic ectoderm; ExVE, extra-embryonic visceral endoderm; P, posterior; PAC, proamniotic canal.
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Amniotic ectoderm expansion in mouse occurs via distinct modes
and requires SMAD5-mediated signalling
Mariya P. Dobreva1,2,*,‡,¶, Vanesa Abon Escalona1,2,3,‡, Kirstie A. Lawson4,¶, Marina N. Sanchez2,
Ljuba C. Ponomarev3, Paulo N. G. Pereira1,2, Agata Stryjewska5, Nathan Criem1,2,3, Danny Huylebroeck5,
Susana M. Chuva de Sousa Lopes6, Stein Aerts2 and An Zwijsen1,2,3,§,¶
ABSTRACT
Upon gastrulation, the mammalian conceptus transforms rapidly
from a simple bilayer into a multilayered embryo enveloped by its
extra-embryonic membranes. Impaired development of the amnion,
the innermost membrane, causes major malformations. To clarify
the origin of themouse amnion, we used single-cell labelling and clonal
analysis. We identified four clone types with distinct clonal growth
patterns in amniotic ectoderm. Two main types have progenitors in
extreme proximal-anterior epiblast. Early descendants initiate and
expand amniotic ectoderm posteriorly, while descendants of cells
remaining anteriorly later expand amniotic ectoderm from its anterior
side. Amniogenesis is abnormal in embryos deficient in the bone
morphogenetic protein (BMP) signalling effector SMAD5, with delayed
closure of the proamniotic canal, and aberrant amnion and folding
morphogenesis. Transcriptomics of individualSmad5mutant amnions
isolated before visible malformations and tetraploid chimera analysis
revealed two amnion defect sets. We attribute them to impairment of
progenitors of the two main cell populations in amniotic ectoderm and
to compromised cuboidal-to-squamous transition of anterior amniotic
ectoderm. In both cases, SMAD5 is crucial for expanding amniotic
ectoderm rapidly into a stretchable squamous sheet to accommodate
exocoelom expansion, axial growth and folding morphogenesis.
KEY WORDS: Amnion, Amnion fate map, BMP-SMAD, Chorion,
Clonal analysis, Extra-embryonic ectoderm, Extra-embryonic–
embryonic interface
INTRODUCTION
Animals classified as amniotes, including reptiles, birds and
mammals, develop extra-embryonic tissues and organs that
perform respiration-related, nutritional and protective functions
during embryogenesis: the chorion, yolk sac, amnion and allantois.
Alongside their supportive role, extra-embryonic tissues take part in
the development of the early embryo proper by providing signalling
cues and spatial continuity (Horn and Panfilio, 2016; Mesnard and
Constam, 2010; Shao et al., 2016). The amnion is the innermost
extra-embryonic tissue that delineates the fluid-filled amniotic
cavity, providing space for the embryo to move freely. The amnion
protects the embryo against traumas, infections and toxins
(Schmidt, 1992). Despite its location at the extra-embryonic–
embryonic interface, the amnion has classically not been considered
a driving force in shaping the early embryo proper. However, in
mice, the expansion of the amniotic cavity is crucial for the
reorientation of notochord cells along the anterior-posterior axis and
for the global morphogenesis of the early embryo (Imuta et al.,
2014). Furthermore, in chickens the physical expansion of
(pro)amnion is required for the correct positioning of the head (de
Melo Bernardo and Chuva de Sousa Lopes, 2014). In humans,
impaired amnion integrity, premature rupture of amnion and
amniotic bands often cause preterm birth and fetal malformations,
including amputations and fetal compression syndromes (Menon
and Richardson, 2017; Opitz et al., 2015). Despite the importance of
amnion, its developmental origin and the molecular regulation of
amniogenesis remain ill-defined.
In the mouse, amnion and chorion development are intimately
related. Early during gastrulation, at embryonic day (E) 6.5-7.0, extra-
embryonic mesoderm emerging from the most posterior part of the
primitive streak (further called ‘streak’) accumulates in the incipient
fold at the posterior extra-embryonic–embryonic junction. This
amniochorionic fold gives rise to both amnion and chorion, but
initially consists only of (prechorionic) extra-embryonic ectoderm.
The epiblast-derived amniotic ectoderm contributes relatively late,
and only to the floor of the fold. The cuboidal chorionic ectoderm thus
greatly exceeds the squamous amniotic ectoderm portion of the fold at
all stages (Pereira et al., 2011). The extra-embryonic mesodermal
layer, still shared by the future amnion and chorion, develops from
the accumulating posterior mesoderm and lines the expanding
exocoelomic cavity. When the fold is fully expanded, the chorionic
walls of the proamniotic canal fuse at the extra-embryonic–embryonic
junction at the embryo’s anterior side, the anterior separation point
(Pereira et al., 2011). This causes amnion-chorion separation, and
partition of the proamniotic cavity into the amniotic, exocoelomic and
ectoplacental cavities at E7.5. Shortly after amnion-chorion
separation, foregut invagination begins, marking the onset of
ventral folding morphogenesis. The flexible amniotic membrane
envelops the entire embryo only on completion of ventrolateral
morphogenesis and body wall closure (Schmidt, 1992).
Several studies indicate that bone morphogenetic protein (BMP)
signalling at the extra-embryonic–embryonic interface is important
for amnion-chorion separation and amnion development in the
mouse (reviewed in Pereira et al., 2011). Binding of BMPs to their
receptors triggers activation by phosphorylation of SMAD1,Received 19 July 2017; Accepted 30 May 2018
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SMAD5 and SMAD9, which co-regulate BMP-responsive gene
expression (Katagiri and Watabe, 2016). SMAD5-deficient
embryos develop severe morphogenesis defects (Chang et al.,
1999; Yang et al., 1999), amnion-chorion separation is delayed and
the anterior separation point is shifted posteriorly (Bosman et al.,
2006). After closure of the proamniotic canal, a striking aggregate of
cells develops anteriorly in the amnion (Chang et al., 1999). These
aggregates ectopically express the mesoderm inducer Nodal, in
addition to T, Fgf8 and Eomes, all established streak mesoderm
markers (Pereira et al., 2012). The aggregates are variable in size,
position and relative composition at E8.5-E9.0. In contrast to the
avascular wild-type (WT) amnion, the aggregates become
vascularized and develop red blood cells and primordial germ cell
(PGC)-like cells (Bosman et al., 2006; Chang et al., 1999), all
posterior streak derivatives. BMP-SMAD signalling is active during
amniogenesis as shown in a BRE::LacZ reporter mouse that
monitors transcriptional activity of phosphorylated BMP-SMAD
proteins (Cajal et al., 2014; Dobreva et al., 2012). Reporter activity
is present in the amniotic ectoderm component of the
amniochorionic fold, the separated amnion, the anterior midline
region distal to the extra-embryonic/embryonic junction and, from
amnion-chorion separation onwards, in the lateral junctions of
amnion with surface ectoderm. In other species, BMP-SMAD
signalling is also crucial for amnion-like tissue development, e.g. in
amniogenesis in human pluripotent stem cell cultures (Shao et al.,
2016), and in defining amnion and serosa or amnioserosa in
different insect species (Rafiqi et al., 2012; Horn and Panfilio,
2016). Furthermore, prominent amniotic expression of BMP4 has
been reported in cynomolgus monkeys (Sasaki et al., 2016).
Little is known about the developmental origin of the amnion,
particularly the amniotic ectoderm (Kinder et al., 2001; Lawson
et al., 1991). To remedy this, wemade a prospective lineage analysis
by labelling single epiblast cells (Lawson et al., 1991) in the
proximal half of WT mouse embryos before and early in
gastrulation (E6.2-E6.5). We identified four distinct types of
clonal growth pattern that expand amniotic ectoderm differently
and with different magnitude. Additionally, we investigated the
earliest steps of abnormal amniogenesis in mice deficient in
SMAD5 by sequencing the mRNA (RNA-seq) of individual control
and mutant amnion samples, and by chimera analysis. Correlating
these data with the clonal analysis supports the conclusion that the
impaired amniogenesis in Smad5mutants results from the two main
cell populations in amniotic ectoderm being affected by the
SMAD5 deficiency.
RESULTS
Amniotic ectoderm is derived from the proximal-anterior and
anterolateral epiblast
To gain insight into the location of amnion progenitors and to trace
their contribution in amniotic ectoderm, we labelled single epiblast
cells in the proximal half ofWTembryos at prestreak (PS) and early-
streak (ES) stages and analysed the resulting clones. Two properties
of single-cell labelling followed by short-term retrospective lineage
analysis were exploited in this approach. First, labelling by
iontophoretic injection enables analysis of clones with known
spatial and temporal origins. It gives fine-resolution fate maps and
the opportunity to reconstruct morphogenetic change from patterns
of clonal expansion during a period of rapid growth. Second,
lineage analysis of prospectively labelled clones allows the clonal
history to be inferred within the cell layer of origin. Thus, the time
trajectory within the amniotic ectoderm, which is continuous with
the epiblast within which the clone arose, can be traced with
confidence retrospectively.
The fate maps of PS and ES stages show that the amniotic
ectoderm is derived mainly from mixed fate progenitors in the
proximal anterior and anterolateral epiblast, whereas amniotic
mesoderm progenitors, also of mixed fate, lie more posteriorly and
distally. These findings are graphically displayed in Fig. 1. From the
Fig. 1. Amnion fate map. Fate maps of amniotic ectoderm and amniotic mesoderm. Top left: cartoon of a midsagittal section of an E6.2, prestreak stage (PS)
embryo. The proximal half of the epiblast cup (blue pattern) is expanded in the right panels and projected on the sagittal midline of PS and early-streak (ES)
stages. Left and right halves of the epiblast are superimposed. Half the circumference of the normalized epiblast is flattened and fitted to its diameter (D), i.e. πD/2
is reduced to D. The primitive streak is represented by a grey stripe. The composition (to the nearest 10%) of clones contributing to amnion is shown as pie charts
at the positions of clone initiation in the two upper panels. Clones not contributing to the amnion are represented by empty circles. Lower panel: composition of the
clones not contributing to amniotic ectoderm in the same region as in the upper panel. Clones contributing to amniotic ectoderm are not represented for clarity.
Scale bar: 50 µm. A, anterior; AVE, anterior visceral endoderm; Epi, epiblast; EPC, ectoplacental cone; EVE, embryonic visceral endoderm; ExEc, extra-
embryonic ectoderm; ExVE, extra-embryonic visceral endoderm; P, posterior; PC, proamniotic cavity.
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triangular-shaped region spanning the anterior midline that
generated amniotic ectoderm, only a minority of labelled
descendants (8%, 245/3032 from 61 clones) were in amniotic
ectoderm. Not all epiblast cells in this region gave rise to amniotic
ectoderm, but the composition of the clones was otherwise
indistinguishable from that of their amnion-contributing
neighbours. This showed an anterior-posterior transition in the
fate map from predominantly surface ectoderm to extra-embryonic
mesoderm (Fig. 1, comparing upper and lower panels). The
amniotic ectoderm therefore develops from a relatively small
number of descendants of proximal-anterior and anterolateral
epiblast that, before and at the onset of gastrulation, is mainly
prospective surface ectoderm and extra-embryonic mesoderm.
Amniotic ectoderm is established via several routes
The detailed findings from the 28 clones that contributed to
amniotic ectoderm are presented in Fig. 2, Table 1 and Fig. S1.
Overall, four clone types were distinguished on the basis of their
distribution within the amniotic ectoderm (Fig. 2) and clone
composition (Table 1).
Type I clones originated in a very restricted region of extreme
proximal anterior/anterolateral epiblast, abutting the extra-
embryonic ectoderm: they were mixed clones with descendants
mainly in extra-embryonic structures, posterior streak and PGCs
(Table 1). Type I clones were found at PS , but not at ES, stage (see
Fig. S2 for possible explanations). These clones spread in the
amniotic ectoderm from the anterior separation point to the posterior
edge of the amnion, indicating that they contributed to the amnion
from its inception: the position of the most anterior cells of these
clones reflected the origin of the progenitors in association with
presumptive chorionic ectoderm. The first amniotic cell of the clone
would have been an extreme posterior (proximal) epiblast or
posterior streak cell in contact with the floor of the early
amniochorionic fold; it then divided, leaving one daughter
associated with the prechorionic ectoderm, the other with the
epiblast/streak. Succeeding divisions expanded the amniotic portion
of the fold. Clones #1 and #2 must have gone through two cell
generations in the epiblast before contributing one cell (clone #1), or
one followed by two (clone #2), to the emergent amnion between
E6.8 and E7.1 (Fig. S1A) at midstreak (MS) to late-streak (LS)
stages [see Fig. 3.5 of Lawson and Wilson (2015) for correlation of
age and stage]. Subsequently, the clones expanded through the
following three or two generations, respectively (Fig. S1A). The
distribution pattern of Type I clones indicates that these clones
Fig. 2. Spread of clone descendants in amniotic ectoderm.Clonal spread in amniotic ectoderm and associated surface ectoderm. Each clone within a type is
identified by a colour/shape combination (Table 1). Top row: the positions of clone progenitors are plotted, as in Fig. 1, on scaled representations of the proximal
half of the epiblast at different initial stages (PS, ES and MS-). Scale bars: 100 µm. The top edge of the diagram is at the junction with the apposing extra-
embryonic (prechorionic) ectoderm. The position of the progenitor of the unplotted Type I PS clone #3 is shown as an empty circle. Lower rows: the view of
clone distribution in the amniotic ectoderm (solid line ellipses) is from dorsal with anterior (A) at the top. The projected positions of the closing/closed proamniotic
canal and node are indicated by an ellipse (dashed line) and an arc (dashed line), respectively. Cells plotted outside the amnion are in the adjacent non-
neural ectoderm (mainly surface ectoderm). The number in the grey crescent at the posterior edge of the amnion is the total number of extra-embryonicmesoderm
and posterior streak cells in the clones expressed as a percentage of the total labelled cells in the embryos contributing to the plot. Clones #2 (Type I, dark blue),
#17 (Type III, dark blue) and #27 (Type IV, light green) are shown in LR mirror image to reduce overlapping in display.
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represent the founding population of the amniotic ectoderm until
amnion closure.
Type II clones originated over a larger area of proximal-anterior
epiblast than Type I. These mixed clones contributed mainly to
extra-embryonic mesoderm, posterior streak and PGCs with
generally only a small minority of descendants in amniotic
ectoderm (Table 1). The contribution was limited to posterior
amnion (Fig. 2), and was slightly later than Type I and over a longer
period (E7.2-E8.1) (Fig. S1B). Hence, Type II descendants moved
into the established primordium and remained as short files that had
not extended further than 15% of the anterior-posterior length of the
amnion by early somite stages (Fig. 2). At the LS stage, the amnion
ectoderm consists of only about 20 cells [EMA10 eMouseAtlas
(Armit et al., 2017)] and, given the behaviour of Type II clones, the
founding population associated with the chorionic ectoderm is
probably complete by this time. Therefore, the founding population
of the amniotic ectoderm appears to be both small and established
within a narrow time window.
Type III clones originated in the proximal quadrant of epiblast
spanning the anterior midline i.e. in prospective surface ectoderm,
which was the main clonal component. Single, small inclusions of
labelled cells in the periphery of the amnion were found between
the axial level of the midbrain and the node (Fig. 2). The size
of the inclusion expanded with the rest of the clone. The inferred
clonal histories (Fig. S1C) indicate that the inclusion of two cells
would have occurred between E7.3 and E7.7 [expected early
preheadfold (EPHF) to late headfold (LHF)], i.e. in the period of
rapid amnion expansion during and after closure, onset of axial
elongation from the node, expansion of the neural folds and
initiation of the foregut. This suggests that inclusion into the
periphery of the amnion from embryonic ectoderm is usually
limited to a period when considerable adjustments to turgor in the
amniotic and yolk sac cavities occur, and when the rostral half of the
embryo is growing rapidly.
Type IV clones originated in extreme proximal anterior to
anterolateral epiblast, spanning the midline. They were generated
between ES+ andMS stages within the same area as the earlier Type
I clones, but were exceptional in being lineage restricted with all
descendants in amniotic ectoderm (Table 1, Fig. 2). The pattern of
clonal spread at late prehead fold (LPHF)/early headfold (EHF)
indicated that early descendants entered the amnion at, or close to,
the anterior midline. They not only expanded the amniotic ectoderm
anterior to the anterior separation point, but also contributed to the
main body of amniotic ectoderm laid down by the original Type I
founding population (Fig. 3A,B). Descendants in somite-stage
embryos were found concentrated mainly between the axial levels of
heart and hindbrain.
An interesting mixed type clone (#28) contributed to the amnion
from both anterior and posterior. The inferred history (Fig. S1D)
indicated that the ES progenitor would have divided twice before one
cell became restricted to amniotic ectoderm (behaving further as
Type IV), and the remaining three cells behaved as Type II,
contributing further descendants to posterior amnion, posterior streak
and allantois. Together, these results indicate that extreme proximal
descendants of PS- or ES-stage epiblast that remain anterior become
part of a relatively late population of exclusively amniotic ectoderm
precursors that expand the amnion specifically from the anterior.
In brief, Type I descendants initiate amniotic ectoderm. Until
closure of the proamniotic canal, Type I and II descendants, both
frommixed fate progenitors, expand the amniotic ectoderm. Around
the time of proamniotic canal closure and after amnion-chorion
separation, the amniotic ectoderm becomes extensively expanded
directly from the anterior by the late-contributing, lineage-restricted
Type IV descendants. Type III descendants expand the amnion
only at the periphery. The behaviour and timing of the different
groups that constitute the amniotic ectoderm are summarized in
Figs 3B and 8A,B.
The amnion of Smad5mutants expresses two
transcriptionally distinct signatures
In normal early somite-stage mouse conceptuses, amnion appears as
a translucent and stretched tissue. In contrast, most Smad5
knockouts (KOs) are distinguished by the presence of a variable
aggregate of cells in the amnion. Additionally, mutants have various
Fig. 3. Illustration and summary of amniotic ectoderm clones. (A) Lateral
view, anterior facing left, and posteriodorsal view (indicated by arrow in lateral
view) of amouse embryowith HRP-labelled Type IV clone (#23) in the amniotic
ectoderm (Table 1, Fig. 2). The clone was initiated close to the midline at the
extra-embryonic–embryonic junction (Fig. 2), as indicated by the VE marker
clone. As the epiblast clone is a pure clone, there is no supporting evidence
about the time of entry of descendants into the amniotic ectoderm. The pattern
of four files of four cells [(1-4)(5-8)(9-12)(13-16)] oriented anterior-posteriorly
indicates that the progenitor divided twice before all four descendants left the
periphery of the amniotic ectoderm during the same cell cycle and went
through two additional cycles of oriented cell division. Two other Type IV
clones (#24 and #27) indicate that cells may divide once or twice at the anterior
periphery while releasing descendants to start populating the anterior amniotic
ectoderm. The asterisk and arrowheadmark the amniotic ectoderm/embryonic
ectoderm junction and the incipient foregut pocket, respectively. Scale bar:
100 µm. (B) Combined distribution (left) of the four types of amniotic ectoderm
clones (Fig. 2) in an LPHF/EHF amnion, and simplified territories (right).
Anterior (A) to the top. The projected positions of the closed PAC and node are
indicated by a small ellipse and arc (dashed lines), respectively. Type I
descendants initiate the primordium and establish the amniotic ectoderm
posterior to the anterior separation point, whereas Type II descendants
populate the most posterior midline subregion. The lineage-restricted Type IV
descendants produce amniotic ectoderm anterior to the ASP, and also
contribute to the already established Type I territory. Type III descendants
expand the amnion only at the periphery. Al, allantois; AmEc, amniotic
ectoderm; AmM, amniotic mesoderm; Ch, chorion; N, node; St, streak; PAC,
proamniotic canal; VE, visceral endoderm.
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ventral folding defects (Chang et al., 1999) (Fig. 4A). Amniotic
ectoderm is cuboidal before aggregate formation, in contrast to the
squamous control amnion, and the junction between amniotic and
embryonic ectoderm is anteriorly less pronounced in all Smad5
mutants (Fig. 4B).
We investigated the molecular differences between WT and
Smad5 mutant amnion by RNA-seq analysis. Amnions were
microdissected (Fig. 4C,D) from control (n=6), and stage-matched
littermate Smad5 knockout (n=6) embryos ranging between EPHF
and three-somite (3S) stages (Table S1), before major morphological
differences become apparent. We synthesized and amplified
cDNA from individual amnion samples. Absence of contamination
with surrounding tissues was confirmed by quantitative reverse-
transcription PCR (RT-qPCR) marker analysis in control samples
(Fig. S3A).
The variance-normalized counts of the RNA-seq data (Table S1)
were used for expression visualization, clustering and differential
gene expression analysis. Unsupervised clustering of all 12 samples
by principal component analysis (PCA) resulted in clustering of five
of six control samples and the segregation of the six knockout
samples into two distinct groups, which we named KO-SetA and
KO-SetB (Fig. 5A). Ctrl6.1 was determined to be an outlier
and omitted from further analysis. Gene set enrichment analysis
(GSEA) of the top differentially expressed genes (adjusted P-value
<0.05) showed that KO-SetA samples were significantly enriched
for categories such as ‘gastrulation’, ‘mesoderm development’
and ‘cell fate specification’, whereas gene sets like ‘integrin
binding’ and ‘regulation of cell adhesion’ were under-represented
(Fig. S3B,C, Table S2, Supplementary Materials and Methods).
Conversely, KO-SetB samples were enriched in categories such as
‘placenta development’ and ‘extra-embryonic ectoderm’, whereas
‘extracellular matrix’ and ‘epithelial-to-mesenchymal transition
(EMT)’ sets were downregulated.
Closer examination of samples with the KO-SetA signature
(Fig. 5B,C, Tables S3 and S4) confirmed and expanded our former
in situ hybridization results on ectopic expression of Nodal, T,
Lefty2, Wnt3 and Fgf8 in Smad5 mutant amnion (Pereira et al.,
2012). Furthermore, KO-SetA samples significantly overexpressed
several markers related to EMT, streak and streak-derived
mesoderm (Fig. 5B,C, Table S3). They include the streak
mesoderm-related Fst (57-fold increase in KO-SetA compared
with control), Zic3 (79-fold); the Nodal co-receptor Tdgf1 or Cripto
(22-fold); and the Nodal target genes Fgf5 (71-fold), Mixl1
(14-fold) and Mesp1 (18-fold). Remarkably, several extra-
embryonic ectoderm markers were robustly enriched in samples
with KO-SetB signature (Fig. 5B,C, Tables S3 and S4). These
included genes such as Elf5 (391-fold more in KO-SetB compared
with control), Esrrb (202-fold), Sox2 (15-fold), Sox21 (107-fold)
and Cldn3 (146-fold).
The two KO sets shared some features. Under-representation of
genes encoding ECM components, such as collagens, and
downregulation of amnion-enriched transcripts like Postn
(Dobreva et al., 2012), Tfap2a and Twist1 (Bosman et al., 2006)
and Flrt3 (Egea et al., 2008), suggested loss of amnion identity
(Fig. 5C, Fig. S3B,C, Table S3 and S4). Eomes – a streak marker
and target gene of Nodal signalling (Arnold et al., 2008), and also a
marker for extra-embryonic ectoderm (Ciruna and Rossant, 1999) –
was found enriched in both KO sets. Target genes of BMP
signalling, such as Smoc2,Postn (Inai et al., 2008) and Flrt3 (Tomás
et al., 2011), were under-represented in both KO sets (Table S3);
however, differential expression of other target genes of BMP/
SMAD5, BMP ligands and modulators of BMP signalling were
specifically observed in KO-SetB samples, e.g. Msx1, Hand1 and
noggin (Nog).
The distribution of KO-SetA and KO-SetB expression profiles
was validated by RT-qPCR in a larger cohort of 25 E7.5 littermate
control-knockout amnion sample pairs. We selected four KO-SetA
(Fgf5, Nodal, T and Lefty2) and four KO-SetB (Elf5, Essrb, Cldn4
and Sox2) genes enriched in one but not the other set (Fig. 5C,
Table S5). One of 25 pairs showed differential expression of only
one of the selected markers, and was therefore not categorized. The
majority of the pairs (64%) segregated either into a KO-SetA (48%)
or KO-SetB (16%) signature (Fig. 5D). Several pairs (32%) showed
an intermediate signature with two or more markers (over)expressed
Fig. 4. Phenotype of Smad5 mutants and amnion
microdissection procedure. (A) Appearance of early somite
stage wild-type (WT) and Smad5 knockout (KO) embryos. The
mutant amnion contains an anteriorly localized tissue aggregate
(arrowhead). Scale bars: 200 μm. (B) Longitudinal sections of
E7.5 LPHF-stage WT and Smad5 KO embryos stained with
Haematoxylin. Amniotic ectoderm (AmEc) is thickened in
mutants (arrowhead). Scale bar: 50 μm. AmM, amniotic
mesoderm. (C) Scheme of a dorsal view of an amnion
positioned to trim it free (see D) from neighbouring tissues;
broken lines represent cuts. Al, allantoic bud; AmM, amniotic
mesoderm; ExM, extra-embryonic mesoderm; VE, visceral
endoderm. Anterior to the left. (D) Amnion microdissection
procedure for an E7.5 LPHF embryo. Following removal of the
proximal (a) and distal (b) parts of the conceptus (cuts at the
broken lines), the extra-embryonic–embryonic junction region
(bracket in c) is flipped 90° and the borders and allantoic bud are
trimmed from the amniotic tissue (d). The remainder of the
conceptus (e) and the isolated amniotic tissue (f ) are used for
genotyping and transcriptome analysis, respectively. Scale
bars: 200 μm.
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from each set. Collectively, the data demonstrate the presence of
two transcriptionally distinct signatures in the amnion of Smad5
mutants. The high prevalence of the intermediate signature suggests
transition from a KO-SetB to a KO-SetA category (progressive loss
of ExEc inclusion features because of ExEc transdifferentiation into
an aggregate), or co-existence of mixed KO-SetA and KO-SetB
phenotypes.
Fgf5 and Elf5, KO-SetA andKO-SetBmarkers, are ectopically
localized in mutant amniotic ectoderm
Subsequently, we documented where the top overexpressed markers
of KO-SetA and KO-SetB localize in mutant amnion. Ectopic T,
Nodal and Wnt3 expression, and Nodal- and β-catenin-mediated
signalling in amniotic ectoderm of Smad5 mutants was previously
documented (Pereira et al., 2012). Here, we show the expression of a
new SetAmarker, Fgf5. Fgf5 is normally expressed in the epiblast at
ES stage, including in the region in which amniotic ectoderm
precursors reside. Its expression is lost anteriorly in the late streak
early allantoic bud (LSEB) and Fgf5 is absent in normal amnion (Li
et al., 2013). We found Fgf5 expressed ectopically in nine of ten
Smad5 EPHF-EHF embryos. The ectopic expression was prevalent
in the anterior embryonic ectoderm and continuous with the anterior
amniotic ectoderm, consistent with the continuous cuboidal
ectoderm shown in Fig. 4B. Its range of extension into amniotic
ectoderm was variable, but could reach as far posteriorly as the
abnormally positioned anterior separation point (Fig. 6A).
Next, we assessed the localization of a KO-SetB marker, Elf5, an
extra-embryonic ectoderm-specific transcription factor (Donnison
et al., 2005) and Oct4/Pou5f1, normally detected in amniotic
ectoderm at EPHF stages (Downs, 2008). In E7.5 control embryos,
amniotic ectoderm was Oct4+ and Elf5–, while extra-embryonic
ectoderm showed Elf5 presence but no Oct4 (Fig. 6B, Ctrl). This
Fig. 5. Differential expression analysis shows two sets of mutants with distinct signatures. (A) Clustering of control (Ctrl) and Smad5 mutant (KO)
amnion samples (details on identity tags of samples are provided in Table S1) by principal component analysis (PCA). The KO samples robustly segregated into
two distinct groups. (B) Volcano plots showing the DESeq2-estimated log2-ratios versus the significance as the negative log10 adjusted P-value (FDR).
Green lines correspond to the used thresholds on the FDR (<0.05) and on the log fold change (<−1 and >1). (C) Expression heat maps for selected transcripts.
The scale indicates variance-stabilized values from minimum to maximum limits of expression values. The mid-values represent the median. Streak/mesoderm
markers are enriched in KO-SetA, and extra-embryonic ectoderm markers (ExEc) are enriched in KO-SetB. (D) Independent validation of RNA-seq findings.
Distribution of mutant expression signatures among 25 littermate knockout/control pair amnion samples based on RT-qPCR for the KO-SetA markers Nodal,
Lefty2, T and Fgf5 (orange) and KO-SetBmarkersCldn4,Elf5,Esrrb andSox2 (green). A knockout was considered to belong to a particular set if it overexpressed
(>3-fold) at least two of the set markers and not more than onemarker of the other set. Knockouts with mixed signature (KO-SetA+KO-SetB) overexpressed two or
more markers of each set. Noncategorized samples are in grey.
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pattern was present in the majority of the mutants (20/25) (Fig. 6B,
KO-SetA). However, in a fraction of the mutants (5/25), a portion of
ectoderm, continuous with the amniotic ectoderm, was strongly
Elf5+ and Oct4– (Fig. 6B, KO-SetB). This pattern did not correlate
with a specific developmental stage (data not shown). The ectopic
presence of Elf5, but also of Eomes (Fig. S4), in amniotic ectoderm
in some mutants is suggestive of inclusion of extra-embryonic
ectoderm, although de novo transcript induction could not be
excluded at this stage.
Tetraploid chimeras support aberrant expansion of amniotic
ectoderm in Smad5mutants
Based on (1) the delayed closure of the proamniotic canal and
amnion-chorion separation in Smad5 knockout embryos (Fig. 6);
(2) the two different KO set signatures (Fig. 5); and (3) the robust
expression of extra-embryonic ectoderm enriched transcripts in the
KO-SetB samples (Fig. 5), we reasoned that a deficit in the amniotic
ectoderm could result in compensatory inclusion of nonamniotic
epiblast tissue and/or trailing extra-embryonic ectoderm into the
mutant amnion.
Tetraploid (4n) complementation assays were performed to
determine whether an extra-embryonic ectoderm inclusion occurs in
the mutant amnion, and whether such inclusions transdifferentiate
into aggregates (Fig. 7A). Donor embryonic stem cells (ESCs) in
ESC↔4n embryo chimeras normally give rise to all epiblast-derived
tissues, including the extra-embryonic mesoderm and amniotic
ectoderm. Conversely, tetraploid descendants are restricted to
trophectoderm derivatives, including chorionic extra-embryonic
ectoderm and extra-embryonic endoderm lineages. The segregation
of descendants of ESCs and tetraploid cells in a chimera thus enables a
distinction to be made between cells of epiblast or extra-embryonic
ectoderm origin. GFP+ WT and Smad5 knockout ESCs (Bosman
et al., 2006)were aggregatedwithGFP− tetraploid embryos (Fig. 7A).
Amniotic ectoderm and amniotic mesodermwere indeed GFP+ in
control chimeras (WT;GFP+ ESC↔4n WT) (Fig. 7B, Fig. S5A).
The majority of the knockout chimeras (Table 2) had uniformly
GFP+ amniotic ectoderm, like the other epiblast-derived tissues.
In most of the E7.5 knockouts (16/21), much of the amniotic
ectoderm was morphologically indistinct from the anterior
embryonic ectoderm (Fig. 7C,D, Fig. S5B). Many of these
embryos (Table 2) displayed a ‘head-out’ phenotype, with the
anterior epiblast/future head region protruding outside the visceral
yolk sac (Fig. 7C, Fig. S5E) as if anterior amniotic ectoderm was
lacking. In a few KO chimeras (3/35, 9%) the GFP+ SMAD5-
deficient posterior amniotic ectoderm appeared undersized and
stretches of tetraploid (GFP−) extra-embryonic ectoderm were
trapped in the amnion (Fig. 7E, Fig. S5G-H).
While nearly all conventional Smad5 knockout embryos develop
an anterior aggregate in the amnion beyond the four-somite stage
(Pereira et al., 2012), only 1/14 E8.5 knockout chimeras had an
anterior aggregate (Fig. 7D). A more posterior thickening was
observed in 5/14 knockout chimeras (Fig. S5C,F). Amniotic
aggregates were always GFP+, confirming their embryonic origin.
Therefore, Elf5+ extra-embryonic ectoderm inclusion is not a
transient state of all Smad5 mutants, but represents a possible
alternative consequence of a posterior amniotic ectoderm deficit in
the absence of SMAD5.
Altered apoptosis, proliferation or ECM production are
unlikely to cause the amniotic deficit
An amniotic ectoderm deficit could result from alterations in
apoptosis or cell proliferation. TUNEL analysis revealed little cell
death in mutant or control conceptuses with no evidence of
increased apoptosis in mutants (Fig. S6), in agreement with
apoptosis-related gene sets being unaltered in mutants in GSEA.
Quantification of proliferation in the ectoderm of the
amniochorionic fold by phospho-histone 3 (PH3) detection
Fig. 6. Ectopic presence of the epiblast marker Fgf5 and the extra-
embryonic marker Elf5 in the mutant amnion. (A) In situ hybridization of
control (EPHF) and two Smad5 knockout (EHF) embryos for Fgf5, a KO-SetA-
enriched transcript. The Fgf5+ segment had a variable extension in the mutant
amniotic ectoderm (KO-SetB embryos, arrowheads). The anterior separation
point (ASP, asterisks), where the proamniotic canal closes and amnion
and chorion separate, shifted posteriorly in mutants. Scale bars: 100 μm.
(B) Longitudinal sections of control and Smad5 knockout embryos stained with
anti-Oct4/Pou5f1 and anti-Elf5 antibodies. Oct4 is present in amnion and Elf5
in chorion in control embryos and in 80% of Smad5 knockout embryos (KO-
SetA embryos), while 20% of the mutants have an Oct4–, Elf5+ segment in the
amnion (KO-SetB embryos, arrowheads). Magnifications of these areas are
shown. The magnified region in the lower right embryo is bracketed by arrows.
Scale bars: 75 μm; 25 μm in magnifications.
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revealed no significant difference in mitotic cells between control
and knockout embryos (Fig. S7A,B).
Altered cell shape, ECM assembly and/or cell-cell and cell-
matrix interactions could affect the squamous architecture and
expansion of the amniotic ectoderm in mutants. GSEA analysis
confirmed robust downregulation in ‘collagen and ECM’-related
gene sets in mutants (Fig. S3B,C, Table S2). This differential
expression could be caused by absence of SMAD5 in amniotic
ectoderm, but could also reflect the relative under-representation of
amniotic ectoderm over trapped nonamniotic tissue. We examined
the spatial protein distribution of the ECM component collagen IV
(ColIV). Normally, the ColIV matrix intertwined between amniotic
ectoderm and mesoderm cells at E7.5 and E8.5 (Fig. S7A,B).
In mutants, ColIV deposition seemed unaffected in regions in which
the amnion was a smooth, thin bilayer. ColIV was, however,
absent from ectoderm in regions with thickened amniotic ectoderm
or an aggregate, and seemed only anchored by amniotic mesoderm
(Fig. S7A,B). Postn, an ECM protein that directly interacts with
fibronectin, collagen I (ColI) and ColIV (Conway et al., 2011;
Horiuchi et al., 1999), had a similar distribution to ColIV in mutants
(Fig. S7C). The differential presence of collagens and Postn in the
amniotic aggregate supported amnion identity being partially
affected. This might result from altered properties of the anterior
amniotic ectoderm in controlling shape and stretchability (anterior
amniotic ectoderm misdifferentiation), or inclusion of nonamniotic
epiblast-derived tissue (epiblast inclusion).
DISCUSSION
Clonal analysis of normal amnion development showed that only a
few descendants of some cells in a restricted area of the early proximal
anterolateral epiblast contribute to amniotic ectoderm development.
These descendants expand the amnion in distinct modes. Type I cells
initiate amniotic ectoderm development and, together with Type II
cells, expand this tissue from the posterior (Fig. 8A,B). Both originate
in the epiblast adjacent to the extra-embryonic ectoderm, which is a
potent source of BMP4 and BMP8B (Ying et al., 2000; Lawson et al.,
1999), in a region that contributes to allantois, PGCs, extra-embryonic
mesoderm and posterior embryonic mesoderm (Fig. 1; Lawson and
Hage, 1994). Type I and II progenitors have co-descendants in exactly
these posterior tissues, and all these tissues are delayed and reduced in
Fig. 7. Tetraploid chimera production confirms
two separate amnion defects in Smad5mutants.
(A) Morula aggregation of control GFP+ ESC↔4n
WT and Smad5−/−;GFP+ ESC↔4n WT assays with
(potential) outcome. The mutant amnion can be
completely epiblast (Epi) derived or can contain an
extra-embryonic ectoderm (ExEc) inclusion
(arrowhead). The latter would result in a GFP–
section in the mutant amnion that might or might not
further transdifferentiate into the aggregate.
(B-E) Chimeric embryos derived from GFP+ WT (B,
E7.5) or Smad5−/− (C-E, left panels) ESCs; and
longitudinal sections of the same embryos stained
with anti-GFP antibody (green). See also Fig. S5.
Epiblast ectoderm inclusion (C,D) as well as ExEc
inclusion (E, arrowhead) were observed. Amniotic
aggregates (D, arrow) were always GFP+. Scale
bars: 100 μm in whole mounts; 50 μm in sections.
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Smad5 mutants (Bosman et al., 2006). Type III clones contribute
facultatively, from the periphery, to amniotic ectoderm, and are
derived from a region (presumptive surface ectoderm) that requires
BMP signalling (Madabhushi and Lacy, 2011). Strikingly, Type IV
progenitors reside in the epiblast spanning the anterior midline of the
extra-embryonic–embryonic junction at ES+/MS, an area that is then
precisely overlain by a restricted source of BMP2 in the anterior
visceral endoderm (Madabhushi and Lacy, 2011). Overall, the
identified progenitor regions are in close proximity to BMP sources,
the relationship being closest for the very restricted, sequentially
present Type I and IV progenitors that generate the bulk of the
amniotic ectoderm.
When relating the clonal analysis results to the Smad5 mutant
embryo analyses (Fig. 8B-D), the consistently delayed and
posteriorized proamniotic canal closure is compatible with a
posterior amniotic ectoderm deficiency resulting from undersized
Fig. 8. Model of normal and abnormal amniogenesis. (A) Schematic
representation of normal amnion expansion. (B) Expression of BMP
ligands and spatiotemporal region of the progenitors of the different
clone types contributing to amniotic ectoderm (regions in respective
colour) at PS, ES and MS stages. Bmp2 (Madabhushi and Lacy, 2011)
and Bmp4 (Lawson et al., 1999) are expressed in the three stages;
the expression of Bmp8b (Ying and Zhao, 2001) in ExEc is only
reported at ES (not shown). Representation of amniotic contribution of
descendants of the four different clone types (Figs 2 and 3B).
(C,D) Two sets of amnion defects occur in Smad5 mutants.
Posteriorized closure of the PAC and ASP (circle with asterisk) are
common to both, indicating a deficiency in Type I descendants
(burgundy arrows). In a few mutants (KO-SetB), a major deficiency in
Type I, descendants, and presumably also a reduced Type II amniotic
ectoderm contribution, causes an early posterior amniotic ectoderm
deficiency leading to cuboidal chorionic extra-embryonic ectoderm
trapping into the amniotic environment at PAC closure (arrowhead) (C).
In most mutants (KO-SetA), the Type IV (and III) population is reduced
(green arrow) with consequent inclusion of nonamniotic epiblast in
amnion, or, alternatively, anterior amniotic ectoderm differentiation
stalls, preventing the cuboidal-to-squamous transition of this epithelium
(both represented by light-blue stripes) (D). In these mutants, the
atypical ectoderm will transdifferentiate into an amniotic aggregate with
posterior streak mesoderm features. Epiblast (D) and extra-embryonic
inclusion (C) defects might occur together, but our data are not
conclusive on this point. Scale bars: 100 µm. AC, amniotic cavity; ACF,
amniochorionic fold; Am, amnion; ASP, anterior separation point; Ch,
chorion; EHF, early headfold; EPC, ectoplacental cavity; EPHF, early
preheadfold; ExC, exocoelomic cavity; LHF, late headfold; LSEB, late
streak early allantoic bud; PAC, proamniotic canal.
Table 2. Mutant chimeric phenotypes resulting from tetraploid complementation assay with Smad5 KO GFP+ ESCs
Stage
ExEc
inclusion
Epiblast inclusion without aggregate Epiblast inclusion with aggregate
Other(1) Total
Head-out and
thick AmEc
Thick
AmEc
Head-
out
Total epiblast
inclusion Anterior Midline Posterior
Total
aggregate
E7.5-E8.0 3 7 9 – 16 – – – – 2 21
E8.5>4S – 1 – 4 5 1 2 3 6 3 14
Total 3 (9%) 8 9 4 21 (60%) 1 2 3 6 (17%) 5 (14%) 35
(1)Other: two chimeras without visible amnion; two chimeras with control phenotype; one very small embryo.
AmEc, amniotic ectoderm; ExEc, extra-embryonic ectoderm.
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or delayed BMP4-dependent amniotic ectoderm founding
population(s) [Type I (and II)]. The inclusion of chorionic extra-
embryonic ectoderm in the amniotic environment of KO-SetB and
some tetraploid chimeras showed that the trailing chorionic portion
of the amniochorionic fold might become trapped in the amnion at
proamniotic canal closure (Fig. 8C).
In the majority of the mutants, the KO-SetA mutants, the
phenotype seems to implicate primarily the Type IV group
(Fig. 8D). In these mutants, the anterior extra-embryonic–
embryonic border is obscure, and the anterior ectoderm is
nonsquamous. One possibility is that the Type IV progenitor
population expands normally in the amniotic ectoderm territory but
fails to acquire the typical expanded squamous morphology of
amniotic epithelium. Alternatively, under-representation of Type IV
descendants is compensated by inclusion of neighbouring anterior
surface ectoderm into the amniotic environment. The RNA-seq
analysis did not directly support such an event as there was no major
differential expression of surface ectoderm markers, such asDlx5 or
Aldh1a3 (Qu et al., 2016); however, low abundant transcripts might
have been under-represented in our study. Conversely, the persistent
expression of the early epiblast marker Fgf5 in the anterior extra-
embryonic–embryonic junction region of the mutants is suggestive
of a stalled epiblast differentiation (atypical anterior ectoderm). In
the absence of specific molecular markers of amniotic ectoderm in
ES/MS embryos, the answer to whether the KO-SetA signature
tissue is caused by misdifferentiated Type IV descendants or
atypical surface ectoderm could potentially be obtained from
prospective lineage analyses at ES+ to LS stages in Smad5mutants.
Further support for SMAD5 being a major signal mediator of
BMP2 in the proximal anterolateral region of the embryo comes
from mice that lack Bmp2 ubiquitously or conditionally in the
anterior visceral endoderm (Zhang and Bradley, 1996; Madabhushi
and Lacy, 2011). Such embryos show defects that are reminiscent of
and equally variable as those in Smad5 mutants (Bosman et al.,
2006; Chang et al., 1999) and tetraploid chimeras; i.e. proamniotic
canal closure defects, severely impaired anterior midline epiblast
tissues and ventral folding morphogenesis defects. However, an
aggregate with posterior streak mesoderm potency in the anterior
part of the amnion seems to form exclusively in Smad5 mutants.
This suggests that SMAD5 deficiency compromises additional
BMP signalling pathways, e.g. BMP4, but potentially also BMP5
that is produced in embryonic mesoderm flanking the anterior extra-
embryonic–embryonic interface (Solloway and Robertson, 1999).
Alternatively, intracellular non-SMAD5 cascades could be
disturbed. Indeed, in cell culture experiments, loss of SMAD5 can
result in gain of Nodal-SMAD2/3 signalling (Pereira et al., 2012).
Indications of such alterations in the Smad5 mutants are the robust
ectopic expression of Nodal and gain of Nodal signalling
(expression of Nodal-SMAD2/3 target genes Lefty2, Eomes,
Cripto, Wnt3) in the nonsquamous cells in anterior amniotic
ectoderm (Pereira et al., 2012) and in the KO-SetA RNA-seq results.
The chimera study showed that the amniotic aggregate is of
epiblast origin, thus excluding that extra-embryonic ectoderm
inclusions (KO-SetB) transdifferentiate into an aggregate with
characteristics of posterior streak mesoderm (KO-SetA mutants).
However, the intermediate expression of selected KO-SetB and KO-
SetA markers in some mutant amnion samples (8/25) is compatible
with ‘mixed’ or variable phenotypes. Whether a mutant develops
into a SetA or SetB phenotype, or ‘anterior’ and ‘posterior’ amniotic
ectoderm defects co-exist, might be a stochastic event. When the
amniotic ectoderm does not stretch fast enough around the time of
proamniotic canal closure, the mechanical forces at the extra-
embryonic–embryonic interface that balance turgor in the
exocoelom and (pro)amniotic cavities might ‘drag’ tissue from
the conceptus into the amniotic ectoderm from wherever there is
least resistance (as normally in Type III clone behaviour).
Interestingly, an extra-embryonic ectoderm inclusion in the
amnion has also been described for Pagr1a knockouts (Kumar
et al., 2014). Pagr1a encodes a protein associated with PAX-
interacting protein 1 (Paxip1) and is predominantly expressed in the
chorion. Its absence results in downregulation of Bmp2 in the
anterior extra-embryonic–embryonic junction.
The driving force behind the cuboidal-to-squamous transition of
amniotic ectoderm still remains unclear. Interestingly, BMP-SMAD
signalling has been reported as a driver of organogenesis by
regulating cell shape and interpreting mechanical forces at the tissue
level (Nerurkar et al., 2017; Poduri et al., 2017; Wang et al., 2012).
It is likely that the increase in turgor associated with the dynamic
expansion of the exocoelomic and amniotic cavities, the folding
morphogenesis of the embryo following amnion-chorion
separation, and/or alterations in cell-matrix and cell-cell
interactions each contribute to significant changes in cytoskeletal
rearrangements. Our study relates BMP-SMAD signalling to these
events in the amniotic ectoderm.
Collectively, the amnion RNA-seq approach and chimera study
have shown that SMAD5 mediates spatial cues crucial for the
establishment of the amniotic ectoderm. The founding population of
the amniotic ectoderm in mouse embryos deficient in SMAD5 is
probably too small or delayed, and the stalled cuboidal-to-squamous
transition of anterior amniotic ectoderm does not keep pace with
exocoelom expansion and axial growth, hindering ventral folding
morphogenesis. The complex and variable amnion phenotypes can
be attributed to SMAD5 loss of function affecting different progenitor
populations for amniotic ectoderm. These arise sequentially from a
distinct region of the anterior proximal epiblast exposed to BMP4 and
BMP2, and expand amniotic ectoderm initially posteriorly and then
from the anterior. Our study also supports a new role for the flexible
amnion, in addition to its known protective function, one in
accommodating the shaping of the embryo proper.
MATERIALS AND METHODS
Embryo culture, single-cell labelling and clone plotting
[C57BL6×CBA.Ca] F1 and F2, and some Dub:ICR mouse (Mus musculus)
embryos were used (Table S6). Terminology of embryo staging was as in
Lawson andWilson (2015). For the nominal age at injection, embryonic day
was counted, with E0 being the middle of the dark period during overnight
mating; 0.1 day was subtracted to allow for the developmental delay as a
result of dissection and labelling. Culture of E6 PS stage and E6.5 ES stage
embryos and the iontophoretic injection of single epiblast cells were
as reported previously (Beddington and Lawson, 1990; Lawson et al. 1991;
Perea-Gomez et al. 2001). In brief, clones were generated by
iontophoretically injecting one epiblast cell/embryo with either a mixture
of 7.4% horse radish peroxidase (HRP, EIA grade, 10814407001, Roche)
and 2.6% lysinated rhodamine dextran (LRDX, Mr 10×103, D1817,
Molecular Probes) or with 10% LRDX alone, both in 0.05 M KCl, using 1-
3 nA depolarising current for 10-20 s, with a duty cycle of 500 ms/s and
frequency of 1 s. An additional injection of 5-10 s into an extra-embryonic
visceral endoderm cell in the same focal plane provided a marker clone in
the same radial position as the injected epiblast cell. Embryos were cultured
for 1 day or 1.5+ days, stained for HRP where relevant, fixed with 5%
paraformaldehyde in PBS, dehydrated and cleared in BABB, when labelled
cells were counted. The location and number of labelled cells were
confirmed on 7 µm serial sections of the material embedded in glycol
methacrylate (Technovit). PGCs were identified on the basis of their
characteristic pattern of alkaline phosphatase activity, in sections of embryos
labelled only with LRDX (Ginsburg et al., 1990; Lawson and Hage, 1994).
11
RESEARCH ARTICLE Development (2018) 145, dev157222. doi:10.1242/dev.157222
D
E
V
E
LO
P
M
E
N
T
Clonal descendants in the amniotic ectoderm were plotted on an
appropriate template using information from the whole mount and
sections to normalize the plot. Amnion templates were derived from 3D
embryo reconstructions in the eMouseAtlas (Armit et al., 2017), specifically
EMA:224 (TS 10b, LSEB/EPHF), EMA:17 (TS 11, LPHF/EHF),
EMA:220 (TS 12a, 2S) and EMA:218 (TS 12b, 5S). Templates were
created from measurements over the surface of the amnion in both sagittal
and frontal orientation. Because of the extreme curvature of the amnion by
the 5S stage, the 2D template for this stage is a compromise between the
linear dimensions over the surface and the shorter periphery of the base of a
dome. Template dimensions were adjusted for 20% shrinkage during
histological processing of the embryos used in the eMouseAtlas.
Smad5mutant mouse strain, microdissection and genotyping
Smad5-deficient mouse embryos (within decidua or isolated) from
heterozygous Smad5−/+ crosses (Smad5tm1Zuk) (Chang et al., 1999) of
mixed C57BL/6J×CBA background were collected in ice-cold PBS at E7.5-
E8.5. Amnion was stepwise microsurgically isolated from EPHF- to 2S-
stage embryos using tungsten needles as shown in Fig. 4C,D, and frozen on
dry ice. PCR genotyping was performed on leftover embryonic material. For
genotyping of embryos sectioned within the decidua, side sections were
mounted on PALM membrane slides (415190-9041-000, Zeiss), stained
with Cresyl Violet and subjected to laser capture microdissection (LCM) on
a PALMMicroBeam laser capture system (Zeiss) to isolate embryonic tissue
for genotyping. DNA for PCR was isolated after on-cap lysis in LCM lysis
buffer (0.5 M EDTA pH 8.0, 1 M Tris pH 8.0 and Igepal CA-630). Sex was
determined by Jarid1c (Kdm5c)/Jarid1d (Kdm5d) and Sry/IL3 PCR
(Table S7). In all experiments, stage-matched Smad5−/+ or Smad5+/+
littermates were used as controls to Smad5−/− embryos. All animal
experiments were approved by the ethical commission of KULeuven (P097/
2008; P077/2014; P251/2014). The care and use of mice complied with the
national and institutional regulatory standards of the Hubrecht Laboratory
(The Netherlands), The University of Edinburgh (UK) and KU Leuven
(Belgium).
RT-qPCR
Primers for RT-qPCR on cDNA from single amnion samples (Table S7)
were designed in maximal proximity to the 3′ ends of target transcripts, to
compensate for the potential 3′ bias that might be generated during
amplification (see ‘Single amnion cDNA amplification’ section). Samples
were processed on a LightCycler480 Real-Time PCR System with
LightCycler 480 SYBRGreen I Master Mix (Roche, 4707516001) in
technical duplicates. Reference genes for amniotic tissue were chosen using
GeNorm. For the analysis in Fig. 5D, expression was normalized to two
reference genes – Gapdh and Psmd4 – using the ΔΔCt method and qbase+
software (Biogazelle). For the analysis shown in Fig. S3A, expression was
normalized to Psmd4, and presented with the ΔCtmethod, which reflects the
Ct difference between the reference and the test transcript (in Fig. S3A, the
higher ΔCt, the higher the expression).
Single amnion cDNA amplification
cDNA for RT-qPCR and RNA-seq was prepared from individual E7.5
amnions and amplified following adaptation of a procedure originally
designed for RNA-seq of single-cells (Tang et al., 2009) on the SOLiD
platform (‘Double-stranded cDNA synthesis from a single cell’, Applied
Biosystems demonstrated protocol). Briefly, reverse transcription and second-
strand cDNA synthesis was performed in the sample lysate without RNA
isolation, using SuperScript III Reverse Transcriptase (Invitrogen) and poly-
dT universal primers. This was followed by two rounds of PCR amplification
(18 and 12 cycles, respectively) and column purifications (QIAquick,
Qiagen), generating up to 3 kb coverage at the 3′ end of all poly-adenylated
transcripts. The resulting cDNA was used for RT-qPCR and RNA-seq. The
cDNA yield for the 12 RNA-seq samples is shown in Table S1.
Whole transcriptome sequencing and bioinformatics analysis
Between 30 and 60 million reads were generated per library; 20%-27% of
them mapped uniquely to the genome (Table S1). Raw colorspace reads
were mapped to the mouse genome GRCm38.83 with TopHat2 software
(v2.1.1) (Kim et al., 2013; Trapnell et al., 2009) using colorspace
compatible parameters: Bowtie 1 (v1.1.2.0), –color –quals and coverage-
search algorithm. Transcript coordinates were extracted from the Genome
Reference Center reference annotation with Gffread from the Cufflinks
v2.1.1 suite and merged to gene coordinates with mergeBed from the
Bedtools v2.17.0 toolkit (Kim et al., 2013; Quinlan and Hall, 2010; Trapnell
et al., 2011). GC content and gene length were derived from the gene
coordinates. The numbers of aligned reads per gene were summarized using
featureCounts v1.5.3 with parameters ‘-Q 0 -s 0 -t exon -g gene id’
(Liao et al., 2014). We removed 22,528 genes for which all samples had
less than 1 count per million. As such, we continued with raw counts for
16,033 genes.
Raw counts were imported in R package DESeq2 1.18.1 (Love et al.,
2014) for library size normalization and differential expression analyses.
The counts were subjected to variance stabilizing transformation (VST)
(Anders and Huber, 2010). The variance normalized counts were used for
gene expression visualization and clustering. Clustering of all 12 samples
was performed by principal component analysis (PCA). In DESeq2, a
negative binomial generalized linear model (GLM) was fitted against the
normalized counts. Differential expression was tested for with a Wald
statistical test, also implemented in the DESeq2 package. The resulting P-
values were corrected for multiple testing with Benjamini–Hochberg to
control the false discovery rate (FDR). Differentially expressed genes were
further filtered using FDR≤0.05 and |log2 FC|≥1. Expression heat maps
were generated in MultiExperiment Viewer (MeV) using VST values.
GSEA analysis is described in the Supplementary Materials and Methods.
Immunohistochemistry, TUNEL assay and whole-mount in situ
hybridization
Embryos and deciduawere fixed overnight in 4% paraformaldehyde in PBS,
embedded in paraffin and sectioned at 6 µm. Fixed chimeric embryos were
pre-embedded in 1.5% agarose prior to paraffin embedding and sectioning.
Fluorescent and chromogenic antibody staining was performed on an
automated platform (Ventana Discovery, Ventana Medical Systems) or
manually using standard procedures. We used antibodies raised against
Oct3/4 (1:100, ab19857), Eomes (1:250, ab23345), collagen IV (1:100,
ab6586), phospho-histone 3 (1:100, ab5176) and GFP (1:100, ab13970)
from Abcam; and Elf5 (1:40, sc-9645) and periostin (1:100, sc-67233) from
Santa Cruz Biotechnology. Differently labelled secondary antibodies raised
in donkey or goat were used (1:300, Jackson ImmunoResearch). Omitting
the primary antibody served as a negative control. Nuclei were
counterstained with DAPI (1:1000, D3571, Invitrogen) or Haematoxylin.
TUNEL assay was performed using a Fluorescein In Situ Cell Death
Detection kit (Roche) according to the manufacturer’s instructions.
Proliferation data were statistically analysed with Prims 6 software
(GraphPad). The nonparametric Mann–Whitney U-test was used for
comparisons of the two groups.
Whole-mount in situ hybridization was performed as previously
described (Pereira et al., 2011). The Fgf5 cDNA template used for
riboprobe synthesis and digoxigenin labelling was generated by PCR
(Table S7). Probe hybridization was at 60°C.
Tetraploid complementation assay and generation of chimeric
embryos
Chimeric embryos were produced as described (Eakin and Hadjantonakis,
2006). Briefly, tetraploidy was achieved by electrofusion of two-cell stage
CD1 embryos. WT and Smad5 knockout mouse ESCs (Bosman et al., 2006)
were transduced with lentivirus containing eGFP gene under the control of
elongation factor 1 alpha promoter. Two tetraploid zona pellucida-free
morula embryos were aggregated with GFP+ ESCs to produce either
Smad5−/−;GFP+ ESC↔4n WT or WT;GFP+ ESC↔4n WT chimeras,
respectively knockout and WT chimeras. Blastocysts were transferred into
the uteri of pseudopregnant females. Embryos were microdissected, imaged
for GFP fluorescence and fixed. In total, 35 knockout and five WT chimeras
were embedded in agarose and paraffin. Sections were subjected to
immunofluorescence against GFP.
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